Display options
Cite
Passos DF, Schetinger MR, Leal DB. Purinergic signaling and human immunodeficiency virus/acquired immune deficiency syndrome: From viral entry to therapy. World J Virol. 2015;4(3):285-94doi: 10.5501/wjv.v4.i3.285.
Passos, D. F., Schetinger, M. R., & Leal, D. B. (2015). Purinergic signaling and human immunodeficiency virus/acquired immune deficiency syndrome: From viral entry to therapy. World journal of virology, 4(3), 285-94. https://doi.org/10.5501/wjv.v4.i3.285
Passos, Daniela F, et al. "Purinergic signaling and human immunodeficiency virus/acquired immune deficiency syndrome: From viral entry to therapy." World journal of virology vol. 4,3 (2015): 285-94. doi: https://doi.org/10.5501/wjv.v4.i3.285
Passos DF, Schetinger MR, Leal DB. Purinergic signaling and human immunodeficiency virus/acquired immune deficiency syndrome: From viral entry to therapy. World J Virol. 2015 Aug 12;4(3):285-94. doi: 10.5501/wjv.v4.i3.285. PMID: 26279989; PMCID: PMC4534819.
Copy Download .nbib Format: NLM
Share it on

World J Virol. 2015 Aug 12;4(3):285-94. doi: 10.5501/wjv.v4.i3.285.

Purinergic signaling and human immunodeficiency virus/acquired immune deficiency syndrome: From viral entry to therapy.

World journal of virology

Daniela F Passos, Maria Rosa C Schetinger, Daniela Br Leal

Affiliations

  1. Daniela F Passos, Daniela BR Leal, Departamento de Microbiologia e Parasitologia, Centro de Ciências da Saúde, Universidade Federal de Santa Maria, Santa Maria, RS 97105-900, Brazil.

PMID: 26279989 PMCID: PMC4534819 DOI: 10.5501/wjv.v4.i3.285

Abstract

Human immunodeficiency virus (HIV) infection is a serious condition associated to severe immune dysfunction and immunodeficiency. Mechanisms involved in HIV-associated immune activation, inflammation and loss of CD4+ T cells have been extensively studied, including those concerning purinergic signaling pathways. Purinergic signaling components are involved in viral entry and replication and disease progression. Research involving the participation of purinergic signaling in HIV infection has been not only important to elucidate disease mechanisms but also to introduce new approaches to therapy. The involvement of purinergic signaling in the pathogenesis of HIV infection and its implications in the control of the HIV infection are reviewed in this paper.

Keywords: Human immunodeficiency virus; Immune activation; Inflammation; Purinergic signaling

References

  1. Front Immunol. 2013 Jan 08;3:414 - PubMed
  2. Pharmacol Rev. 2006 Mar;58(1):58-86 - PubMed
  3. Virology. 2012 Oct 10;432(1):219-31 - PubMed
  4. Curr HIV Res. 2011 Jun;9(4):209-22 - PubMed
  5. Biochim Biophys Acta. 2008 May;1783(5):673-94 - PubMed
  6. Clin Exp Immunol. 2013 Jan;171(1):1-7 - PubMed
  7. J Leukoc Biol. 2013 Sep;94(3):390-2 - PubMed
  8. Prog Neurobiol. 2011 Oct;95(2):229-74 - PubMed
  9. Nature. 2014 Jan 23;505(7484):509-14 - PubMed
  10. Biofactors. 2007;31(2):77-98 - PubMed
  11. Biochim Biophys Acta. 2005 Jan 18;1721(1-3):9-15 - PubMed
  12. J Virol. 2014 Oct;88(19):11504-15 - PubMed
  13. Nat Rev Immunol. 2011 Mar;11(3):201-12 - PubMed
  14. Retrovirology. 2008 Mar 28;5:30 - PubMed
  15. Annu Rev Med. 2011;62:141-55 - PubMed
  16. Retrovirology. 2010 Jun 22;7:54 - PubMed
  17. Immunol Cell Biol. 2009 Nov-Dec;87(8):634-9 - PubMed
  18. Immunity. 2011 May 27;34(5):637-50 - PubMed
  19. FEBS J. 2009 Jan;276(2):318-29 - PubMed
  20. Lancet. 2014 Jul 19;384(9939):258-71 - PubMed
  21. PLoS Pathog. 2011 Jul;7(7):e1002110 - PubMed
  22. Cell Death Dis. 2013 Jul 11;4:e718 - PubMed
  23. Physiology (Bethesda). 2009 Oct;24:298-306 - PubMed
  24. Blood. 2011 May 19;117(20):5372-80 - PubMed
  25. Braz J Med Biol Res. 2009 Jan;42(1):3-8 - PubMed
  26. J Acquir Immune Defic Syndr. 2012 Jul 1;60 Suppl 1:S1-18 - PubMed
  27. Antioxid Redox Signal. 2011 Oct 15;15(8):2221-34 - PubMed
  28. Sci Signal. 2008 Sep 30;1(39):ra6 - PubMed
  29. Biochim Biophys Acta. 2005 Dec 15;1746(2):129-34 - PubMed
  30. Mol Pharmacol. 2007 Oct;72(4):856-67 - PubMed
  31. Pharmacol Rev. 1998 Sep;50(3):413-92 - PubMed
  32. Cell Mol Life Sci. 2007 Jun;64(12):1471-83 - PubMed
  33. Virology. 2004 Oct 1;327(2):186-95 - PubMed
  34. Purinergic Signal. 2007 Mar;3(1-2):1-3 - PubMed
  35. Cancer Res. 2012 Nov 1;72(21):5441-7 - PubMed
  36. J Leukoc Biol. 2007 Aug;82(2):220-5 - PubMed
  37. Immunol Rev. 2011 Sep;243(1):206-14 - PubMed
  38. J Cell Physiol. 1983 Mar;114(3):279-83 - PubMed
  39. HIV AIDS (Auckl). 2010;2:39-49 - PubMed
  40. Biochem J. 1992 Dec 15;288 ( Pt 3):897-901 - PubMed
  41. J Immunol. 2010 Aug 15;185(4):1993-8 - PubMed
  42. J Virol. 2011 Feb;85(3):1287-97 - PubMed
  43. J Leukoc Biol. 2011 Jan;89(1):127-36 - PubMed
  44. Immunol Lett. 2014 Nov;162(1 Pt B):329-33 - PubMed
  45. J Immunol. 2012 May 1;188(9):4488-95 - PubMed
  46. J Pathol. 2008 Jan;214(2):231-41 - PubMed
  47. AIDS. 2013 Jun 1;27(9):1513-6 - PubMed
  48. Physiol Rev. 2007 Apr;87(2):659-797 - PubMed
  49. AIDS. 2013 May 15;27(8):1199-208 - PubMed
  50. J Neuroimmune Pharmacol. 2014 Mar;9(2):233-44 - PubMed
  51. PLoS One. 2012;7(12):e51287 - PubMed
  52. Bioessays. 2012 Mar;34(3):218-25 - PubMed
  53. Nat Rev Microbiol. 2009 Feb;7(2):99-109 - PubMed
  54. AIDS. 2013 Jun 19;27(10):1545-55 - PubMed
  55. Sci Signal. 2009 Feb 03;2(56):pe6 - PubMed
  56. J Clin Immunol. 2013 Apr;33(3):605-12 - PubMed
  57. Sci Signal. 2010 Jan 12;3(104):re1 - PubMed
  58. Blood. 2013 Jan 3;121(1):29-37 - PubMed
  59. PLoS One. 2013 May 22;8(5):e64702 - PubMed
  60. Cold Spring Harb Perspect Med. 2012 Dec 01;2(12):a007443 - PubMed
  61. Intervirology. 2014;57(1):36-42 - PubMed
  62. Mech Ageing Dev. 2007 Jan;128(1):92-105 - PubMed
  63. Nat Rev Immunol. 2011 Mar;11(3):176-86 - PubMed
  64. Cell Death Dis. 2012 Oct 11;3:e403 - PubMed
  65. PLoS Pathog. 2013;9(4):e1003319 - PubMed
  66. Keio J Med. 2013;62(3):63-73 - PubMed
  67. PLoS One. 2012;7(1):e29291 - PubMed
  68. J Exp Med. 2011 Aug 29;208(9):1823-34 - PubMed
  69. Trends Microbiol. 2013 Jan;21(1):6-13 - PubMed
  70. Nat Rev Microbiol. 2012 Sep;10(9):655-66 - PubMed
  71. Annu Rev Physiol. 2012;74:153-75 - PubMed
  72. Curr Opin HIV AIDS. 2013 May;8(3):182-9 - PubMed
  73. Adv Physiol Educ. 2013 Dec;37(4):284-91 - PubMed
  74. Immunol Lett. 2014 Oct;161(2):184-8 - PubMed
  75. Trends Pharmacol Sci. 2006 Apr;27(4):211-7 - PubMed
  76. Future Virol. 2013 Jan;8(1):81-101 - PubMed
  77. Cold Spring Harb Perspect Med. 2012 Sep 01;2(9):a007005 - PubMed
  78. J Neuroimmune Pharmacol. 2013 Sep;8(4):998-1009 - PubMed
  79. Purinergic Signal. 2010 Sep;6(3):307-15 - PubMed
  80. Front Physiol. 2014 Mar 14;5:96 - PubMed
  81. J Am Soc Nephrol. 2009 Jun;20(6):1275-81 - PubMed
  82. Lab Invest. 2014 Feb;94(2):120-8 - PubMed
  83. N Engl J Med. 2012 Dec 13;367(24):2322-33 - PubMed
  84. Microb Pathog. 2014 Aug;73:60-9 - PubMed
  85. Microbes Infect. 2012 Nov;14(14):1278-83 - PubMed
  86. J Leukoc Biol. 2013 Sep;94(3):399-407 - PubMed
  87. Clin Microbiol Rev. 2013 Jan;26(1):2-18 - PubMed

Publication Types